Hilary Kramer

Hilary Kramer

Hilary Kramer is one of Wall Street’s most successful equity analysts and investment managers, with a reputation as a leading expert on today’s market movements, stock trends and economic outlook.

She received her MBA from the Wharton School at the University of Pennsylvania and her BA from Wellesley College with honors. Hilary Kramer got her start on Wall Street more than two decades ago at Lehman Brothers and Morgan Stanley where she was an analyst in the investment banking group covering natural resources, diversified industrials and energy companies. She was also the chief investment officer of a family office — overseeing a $5.2 billion global private equity and publicly-traded equity fund, and co-vice chairman of the $500 million Ibero-American Partners Fund (1997 to 2003).

In 2004, Hilary’s A&G Capital formed a specialized research arm and investment fund. The GreenTech 21st Century Master Fund focused on companies engaged in alternative energy, clean technologies, environmental infrastructure and services, agricultural and natural resources.

Today, Hilary Kramer is an in-demand commentator whose work often appears in investing publications such as the Wall Street Journal, New York Post, Bloomberg, Business Insider and Reuters and is a regular on CNBC, CNN and the Fox News Channel, providing stock market insight and economic observations.

Hilary Kramer is also the editor of several financial advisory services designed to help individual investors profit from her stock picking talents: Value Authority, GameChangers, Breakout Stocks, High Octane Trader, Absolute Capital Return, Inner Circle and Inner Circle Pro.

Recent Articles

CREE Stock Looks Strong Amid Market Volatility

The market is in the midst of some stomach-churning events, but investors with money in cutting edge technologies like CREE stock should weather those storms

Liberator Medical Stock Is a New Growth Buy – LBMH

Liberator Medical is a medical supplies distribution company with solid cashflow and growing revenues. Read more about this new stock to buy right here....

Missed My Latest Stock Picks and Trends? Catch Up Here!

Here is your opportunity to see what I've been saying about stocks, the stock market and other topics over the past month. You don't want to be left behind!

3 Biotechs to Buy and 1 to Sell Now

Biotechs are a sector where the whisper of FDA approval can send stocks soaring or falling. Here are 4 biotech stocks to watch for 2014, including 3 buys

SWI: SolarWinds a Virtual Winner for Investors

SolarWinds is an enterprise software company helping businesses manage data and cut costs. IT spending will grow in 2014; here's a virtualization play